
Motion control underpins modern medical devices such as surgical robots, imaging systems, and laboratory instruments, yet it remains a complex engineering hurdle. Dave Beckstoffer of Portescap highlights how early, collaborative partnerships with motion‑control specialists can streamline development and boost reliability. Regal Rexnord unites its brands—Portescap, Kollmorgen, and Thomson—into a unified portfolio that delivers system‑level, validated motion subsystems from prototype through production. This approach reduces integration risk, shortens time‑to‑market, and supports regulatory compliance for medtech OEMs.

The Patient‑Centered Health Technology Initiative (PHTI) released a Clinical AI report built from a workshop with senior leaders across health systems, insurers, tech firms, and federal agencies. Participants identified policy, reimbursement, and evidence gaps as primary barriers to scaling AI...
Otsuka Medical Devices and Otsuka Pharmaceutical announced that Japan’s National Health Insurance will cover the Paradise™ Ultrasound Renal Denervation (uRDN) system starting March 1, with commercial sales beginning March 2. The device, developed by Recor Medical, targets resistant‑hypertension patients who remain uncontrolled...

The article argues that early‑stage medical device ideas require a balanced communication approach that avoids both silence and hype. It highlights the tension trainees and researchers feel when sharing untested concepts and proposes focusing discussions on problems, trade‑offs, and unknowns...

The AI Medical Services Act (AMSA) creates a new licensure category for AI-driven clinical tools, mandating tiered risk oversight, physician supervision, and a regulatory sandbox for limited deployments. It embeds bias monitoring, adverse‑event reporting, and a framework for Medicaid and...

Epic Systems announced its first pharmaceutical customer, Eli Lilly, for the newly launched Epic Discovery platform. The deal marks the inaugural sale of a Health Grid product to a life‑sciences firm, allowing Lilly to streamline clinical trial creation, site identification, activation,...

The GSMA announced a strategic partnership between its Foundry innovation hub and Singapore’s National University Health System (NUHS) to accelerate 5G‑enabled, AI‑driven healthcare solutions. The collaboration will focus on private 5G networks, digital twins, XR, IoT and ambient AI to...
RevolutionEHR introduced RevPay, an embedded payments solution that integrates checkout, patient records, and reporting within its AI‑native platform. The tool supports card, ACH, digital wallets and offers optional patient surcharging, promising to reduce processing fees that can cost $10,000‑$18,000 annually...

Hospitals now host dense networks of temperature, humidity, CO₂, pressure and filtration sensors, delivering unprecedented operational visibility. While building management systems excel at real‑time control, they were never built to serve as immutable evidence. The industry faces a growing demand...
Median Technologies announced it will present at TD Cowen’s 46th Annual Health Care Conference in Boston from March 2‑4, 2026. CEO Fredrik Brag will discuss the company’s latest AI‑driven SaMD developments and upcoming milestones on March 4 at 11:10 am ET. The presentation will be...
CFG Health launched CareLink, a proprietary 24/7 telehealth platform designed for correctional facilities. Built on existing security‑issued tablets, the solution delivers emergency triage, primary, behavioral, and specialty care while maintaining HIPAA compliance. The platform combines CFG’s in‑house clinicians with external...
Acupath Laboratories has partnered with Azer Scientific to install the first AzerView LH510 digital pathology scanner in the United States. The LH510 offers high‑resolution whole‑slide imaging and streamlined workflow features designed for clinical, academic, and reference labs. The installation marks...

The San Francisco Tech Council launched a state‑funded program that teaches low‑income, limited‑English‑proficiency patients how to use online medical portals. Participants received a 45‑minute hands‑on session with a digital navigator, enabling them to schedule appointments, view results, and request prescriptions. Feedback...
Cowellnex Co., Ltd. and Metagen, Inc. will begin joint research in February 2026 to create new gut‑microbiota test items and a personalized food‑recommendation algorithm using Cowellnex’s three‑year shotgun metagenomic dataset. The partnership leverages Cowellnex’s high‑precision Japanese microbiome data and Metagen’s...

Researchers introduced MICRO, a multimaterial, single‑step 3D‑printed electrochemical device that integrates electrodes, microfluidic channels, and housing in one build. By leveraging dual‑extrusion printing of conductive and insulating polymers, the platform eliminates wiring, sealing, and machining steps traditionally required for screen‑printed...
Weave (NYSE: WEAV), the AI‑driven patient engagement SaaS provider, announced it will present at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 in Orlando. CEO Brett White and CFO Jason Christiansen will lead a fireside‑chat at 4:35 pm ET, followed by...
Sun Nuclear launched its 15th QA & Dosimetry Symposium (QADS) in Rome, gathering more than 230 clinical physicists from nearly 40 countries. The event introduced the Daily QA 4 Pro, a combined dosimetry‑imaging device designed to streamline daily machine quality checks. Demonstrations also...
Oregon and Oklahoma are set to launch their own state‑based ACA exchanges, bringing the total to 23 states (including DC) that will operate independent marketplaces by 2028. This shift will push state‑run exchanges past the 50 percent population mark, a milestone...
YOU(th) has secured US$4.5 million to scale its AI‑driven smartphone health‑screening platform, which evaluates over 50 digital biomarkers in under two minutes. The round was led by Callisto Health with participation from caesar., adesso Ventures, Antler, Moonstone, 1024 Ventures and notable...
Takeda is leveraging real‑world evidence (RWE) and human‑focused AI to reshape clinical trial design, patient access, and global market strategies. Chief Medical Officer Awny Farajallah highlights three pillars: robust evidence generation, capability building, and early patient access. RWE is used...
Chronic liver disease in the UK is often identified only after emergency admission, with more than a third of such patients dying within a year. Stigma and competing primary‑care priorities leave up to 80 % of MASH cases undiagnosed, driving rising...

Buzz Health President Joseph Kleiman says TrumpRx is advancing drug‑price transparency by giving consumers early visibility into prescription costs. He notes that real‑time pricing can help patients compare options but also warns that prices are dynamic and may change before...
Women’s HealthX (WoHX) will convene 750 pharma, biotech, hospital, insurer, startup and government leaders in Boston on December 3‑4, 2026. The two‑day summit aims to close the sex‑difference data gap by showcasing evidence‑based technologies, AI tools and digital therapeutics across the...
Altius launched Alti, an AI‑driven life‑quality companion aimed at employers and health systems. The platform claims 96% of users feel better, with stress, anxiety and depression dropping 48% and chronic‑disease risk falling 40%. For organizations, Alti reportedly lifts productivity by...
Researchers at Tokyo University of Science have created a water‑based enzyme ink that allows screen‑printing of both anode and cathode layers of enzymatic biofuel cells in a single step. The printed lactate/oxygen biofuel cell delivered a peak power density of...

Chamber Cardio announced a $60 million Series A round in February 2026, led by Frist Cressey Ventures and backed by General Catalyst, Optum Ventures, Healthworx and other investors. The startup offers a two‑sided platform that connects payers with cardiology practices, embedding workflow‑native AI...

Brazil spends roughly US$75 billion annually on medicines through its universal health system, but fragmented procurement across 5,000 municipalities creates price volatility and opaque documentation. A coalition of government agencies and civil‑society groups launched the Medicamentos Transparentes platform, which consolidates purchase...
Brainomix announced a £18.8 million Series C extension, adding £4.8 million to accelerate its AI‑driven imaging platforms. The capital will fund rapid US deployment of Brainomix 360 Stroke, which automates acute stroke assessment, and E‑Lung, a CT‑based tool for fibrosing lung disease. The company, already...

Sibel Health and LookDeep Health announced a strategic partnership that merges Sibel’s FDA‑cleared ANNE® One wearable, which continuously captures clinical‑grade vitals, with LookDeep’s aimee™ bedside AI that adds real‑time visual and audio context. The combined platform targets emergency departments, general...

Illumina has rebranded its Constellation mapped‑read system as TruePath Genome and launched it commercially at $395 per genome. The technology performs on‑flowcell tagmentation of high‑molecular‑weight DNA, using DRAGEN to infer proximity and generate haplotype blocks on NovaSeq X 10B flowcells. TruePath Genome claims...
A Parallels survey of 600+ global IT leaders found 94% fear vendor lock‑in, especially in health systems where platforms now underpin clinical, security and data functions. The study shows a shift from cost‑avoidance to protecting organisational freedom, prompting hybrid and...

The Digital Health Rewired 2026 conference programme, featuring ten themed stages, has been released. More than 300 senior health‑IT leaders, including NHS CEOs, CIOs, CCIOs and CNIOs, will present sessions on digital transformation, cyber security, AI, and electronic patient records....

Researchers at Shanghai Xuhui District Stomatological Hospital and the Chinese Academy of Sciences have engineered a vibration‑activated teeth‑whitening powder (BSCT) that works with electric toothbrushes. The ceramic powder uses piezoelectric catalysis to generate reactive oxygen species for stain removal while...
NVIDIA’s second State of AI in Healthcare report shows AI moving from experimentation to profit across radiology, drug discovery, medical devices and digital twins. Seventy percent of respondents now actively use AI, up from 63% a year earlier, and 69%...
Mevion Medical Systems announced that its S250‑FIT proton therapy system has received CE marking under EU MDR, allowing marketing and clinical use across the European Union. The compact, LINAC‑vault‑ready platform, already cleared by the U.S. FDA, fits into standard radiation...

Carea has introduced a new "Trying to Conceive: IVF/IUI" mode within its pregnancy and postnatal wellbeing app, offering a day‑to‑day support system for women undergoing fertility treatment. The feature includes a personalised medication tracker, video guides, reminders, and a visual...
Sleep Cycle and Carnegie Mellon University's Delphi Group have launched a five‑year research collaboration to test whether privacy‑preserved sleep data—particularly nightly cough intensity captured by Sleep Cycle’s Cough Radar—can augment traditional respiratory disease surveillance. The partnership will share de‑identified data...
Galderma announced that regulatory agencies in the European Union, United States and Canada have approved a new state‑of‑the‑art Restylane® syringe for use with its NASHA® lidocaine filler line. The device is cleared for a broad set of facial areas—including cheeks,...
HekaBio K.K. and Alpha Tau Medical have secured Japanese regulatory approval for Alpha DaRT, a diffusing alpha‑radiation therapy for unresectable locally advanced or recurrent head‑and‑neck cancer. The approval makes Japan the first country outside Israel to clear the device, positioning HekaBio...
Fabric announced Evo, a nationwide virtual‑care benefit launching Jan. 1 2026 to replace MeMD. The platform merges everyday urgent care, talk therapy, mental‑health medication management, and weight‑loss into a single digital front door. Using an async‑first model, Evo can generate personalized treatment...
X‑on Health has launched Omni Consult, an upgrade to its Surgery Connect platform that unifies patient request channels into a single, structured workflow. The solution lets patients submit requests via voice agents, web forms or staff entry, consolidating them for GP...
The article revisits the long‑standing self‑versus‑non‑self paradigm in immunology, highlighting fetal immune tolerance as a natural exception. It explains how maternal‑fetal microchimerism and epigenetic plasticity challenge traditional dogma and could unlock new treatments for auto‑immune disease, cancer, and age‑related inflammation....

AI‑driven coding assistants are slashing healthcare software development costs by 80‑90%, turning what was once a multi‑year, eight‑figure project into a matter of weeks or days. This cost collapse erodes the traditional moat of EHR and point‑solution vendors, enabling hospitals,...
A preclinical study published in eGastroenterology demonstrates that lipid‑nanoparticle delivery of nucleoside‑modified mRNA encoding anti‑PD‑L1 nanobodies suppresses tumor growth in mouse models of both sporadic and colitis‑associated colorectal cancer. Researchers engineered monomeric and quadruple nanobody formats; the quadruple construct showed...

Medical device maker Medi‑Globe has launched mAI Companion, a CE‑marked real‑time AI assistant for pancreatic endoscopic ultrasound (EUS). Developed with IHU Strasbourg, the system analyses the pancreas during procedures to highlight solid and cystic lesions, acting as a second set...
Natera reported Phase 2 SINERGY trial results showing a 63% objective response rate in recurrent or metastatic head and neck squamous cell carcinoma when treatment was adapted using Signatera circulating tumor DNA monitoring. Seventy‑four percent of the 27 patients were de‑escalated...
Ireland has unveiled a €1 million digital mental health strategy that outlines a national roadmap for digital tools, shared records and technology‑enabled services. The plan builds on the 2020‑2030 "Sharing the Vision" policy and prioritises the HSE Health App, a national...

At a recent round‑table, a speaker outlined how the NHS 10‑year plan can be accelerated by applying platform‑centric principles drawn from the Platformland framework. The presentation highlighted four pillars: digital ways of working, platform‑based clinical functions, converting the public into...

MiraDx has launched PROSTOX Standard, a clinically validated genetic test that predicts long‑term urinary toxicity for prostate cancer patients receiving conventional or moderately hypofractionated radiation therapy. The test uses a cheek swab and returns results in five to seven days,...

Orthonika, an Imperial College London spin‑out, received FDA Breakthrough Device Designation for its synthetic Total Meniscus Replacement (TMR) implant and an invitation to the Total Product Life Cycle Advisory Program. The designation promises prioritized regulatory engagement, speeding the path to...